Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-25-011177
Filing Date
2025-03-21
Accepted
2025-03-21 20:00:06
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2754
  Complete submission text file 0001493152-25-011177.txt   4253
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SHUTTLE PHARMACEUTICALS HOLDINGS, INC. 401 PROFESSIONAL DRIVE, SUITE 260 GAITHERSBURG MD 20879
Business Address
Tung Joseph (Reporting) CIK: 0002060609 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41488 | Film No.: 25761996